Development of vaccines and monoclonal antibodies for human herpesviruses, studies of genetic variants and immune defects in persons with severe virus infections.
Jeffrey I. Cohen, M.D.
Chief, Laboratory of Infectious Diseases
Chief, Medical Virology Section
Provides direct clinical care to patients at NIH Clinical Center
M.D., Johns Hopkins University
Dr. Cohen received his M.D. from The Johns Hopkins University and was a resident in medicine at Duke University. Following a medical staff fellowship at the National Institutes of Health (NIH), he was a clinical fellow in infectious diseases at the Brigham and Women’s Hospital and an instructor in medicine at Harvard University. He returned to NIH, where he was the chief of the Medical Virology Section in the Laboratory of Clinical Infectious Diseases until 2010. In June 2010, Dr. Cohen became chief of the Laboratory of Infectious Diseases.
Mir A. Ali, Ph.D. (He/Him/His)
Ph.D., Biochemistry-Immunology, Indian Institute of Science, Bangalore (now Bengaluru), India
Languages Spoken: Urdu, Hindi, Tamil
Wei Bu, Ph.D. (He/Him/His)
Ph.D., Rutgers Medical School, New Jersey
Languages Spoken: Mandarin, Chinese
Kennichi Dowdell, Ph.D.
Ph.D., Neuroscience, Ohio State University
B.S., Biology, B.A., Psychology, Indiana University of PA
Support all lab projects and general lab functions. Work to determine the underlying genetic and immunological changes associated with the pathology of uncontrolled viral infections.
Anna Elizabeth Hostal, B.S. (She/Her/Hers)
Postbaccalaureate Research Fellow
B.S., Biochemistry, minor in Spanish, Arizona State University
Languages Spoken: Spanish
Anna Hostal is currently developing monoclonal antibodies for Epstein-Barr Virus (EBV) and investigating their interaction with viral antigens. Through this work she hopes to better understand the mechanisms of viral fusion to inform the rational design of future therapeutics and vaccines.
Tammy A. Krogmann, B.A., B.S.
B.A., English, University of Minnesota Duluth
B.S., Biology, University of Minnesota Duluth
Have performed studies to identify viruses in human tissues, evaluation of specimens from subjects for COVID-19 studies, cloning for VZV and EBV projects, and antibody discovery for EBV.
Lui Phillip Suzuki-Williams, B.S. (He/Him/His)
B.S., Biochemistry and Molecular Biology, University of Georgia
Lui Suzuki-Williams is developing an assay to measure the efficacy of mAb and vaccine sera to block HSV-2 cell-cell fusion. He is working on a longitudinal COVID-19 study and an HSV-2 animal study. His research interests include immunology, infectious diseases, and virology.
Alexander Charles Vostal M.D. (He/Him/His)
Clinical Research Fellow
M.D., Uniform Services School of the Health Sciences, Bethesda, MD
B.S., Microbiology/Immunology, University of Rochester, Rochester, NY
Dr. Alexander Vostal is an active-duty officer in the United States Public Health Service and a Clinical Research Fellow in the Laboratory of Infectious Diseases of the National Institutes of Allergy and Infectious Diseases.
Kening Wang, M.D.
M.D., Zhejiang University Medical School (former Zhejiang Medical University), Hangzhou, Zhejiang, P.R. China
Languages Spoken: Chinese
Joined NIAID in 1992. Current research focuses on herpes simplex virus (HSV) prevention including designing, producing, and characterizing novel HSV-2 vaccine candidates, and developing animal models for characterizing HSV-2 vaccine candidates.